go-v.orgdoi

Improving diagnostics and quality of life in children with peanut allergy and other atopic diseases

Hannah M. Kansen · Utrecht University Repository (Utrecht University) · 2020

  • DOI 10.33540/162
  • Publisher Utrecht University
  • Type dissertation
  • Issued 2020

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Utrecht University Repository (Utrecht University) · Utrecht University · dissertation · 2020

Abstract

BackgroundSeveral studies showed that sIgE to Ara h 2 is a good predictor of peanut allergy and may reduce the need for double-blind placebo-controlled food challenges (DBPCFCs), yet validation and implementation in clinical practice has not been studied. ObjectiveTo validate previously published Ara h 2 cutoff levels and implement a diagnostic flowchart to evaluate its 1) diagnostic performance, 2) costs and 3) impact on patients.

MethodsPhysicians of tertiary (n=1) and secondary (n=3) care centers were instructed to use a flowchart in 150 children with suspected peanut allergy based on the Ara h 2 level (kU A /L): ≤0.1 home introduction, 0.1-5.0DBPCFC and ≥5.0 open food challenge.The costs of the flowchart were calculated using financial healthcare data and were compared to the costs of a diagnosis according to the guideline.The State-Trait Anxiety Inventory was administered at baseline, after Ara h 2 was communicated and after 6 months.Results The diagnostic flowchart correctly classified 100% of children with Ara h 2 ≤ 0.1 kU A /L as peanut-tolerant and 89-97% of children with Ara h 2 ≥ 5.0 kU A /L as peanut-allergic.None of the children with Ara h 2 ≤0.1 kU A /L experienced allergic symptoms during (home) introduction.Mean annual costs of the flowchart were €320-€636 per patient lower compared to the guideline.Parental state anxiety was lower after an Ara h 2 result ≤ 0.1 kU A /L compared to baseline.

ConclusionAra h 2 cutoff levels are validated in secondary and tertiary care.Furthermore, the diagnostic flowchart is accurate, safe and reduces costs in children.

Open the resolved locator · 10.33540/162

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 04:12 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.33540/162
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.